Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	DrugBank	Drug (Description in trials)	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Bezafibrate	[10] Bezafibrate; Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour udca therapy; Bezafibrate (drug); Bezafibrate (inn 3968); Bezafibrate 200 mg; Bezafibrate 400 mg; Bezafibrate ir; Bezafibrate sr; Bezafibrate, beza, bzf, bezalip; Bezafibrate, beza, bzf, bezalip mono;	[1] D01366 💬	[1] PPARA 💬	[8] Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway	[6] 20, 93, 94, 160, 316, 324 💬
2	Elamipretide	[4] Elamipretide; Elamipretide (high dose); Elamipretide (intermediate dose); Elamipretide (low dose);	[1] D10925 💬	-	-	[2] 21, 324 💬
3	Triheptanoin	[5] Triheptanoin; Triheptanoin / triheptanoina; Triheptanoin 1g/kg/day; Triheptanoin oil; Triheptanoina;	[1] D11465 💬	-	-	[9]  2 ,  8 , 149, 156, 248, 256, 257, 317, 324 💬